Real-time enrollment status for this borderline resectable pancreatic ductal adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 4:37 PM UTC
| NCT Number | NCT06821997 |
| Recruiting Status | Recruiting |
| Condition | Borderline Resectable Pancreatic Ductal Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Roswell Park Cancer Institute |
| Last Updated on CT.gov | April 1, 2026 (Apr 1, 2026) |
As of July 18, 2026: Clinical trial NCT06821997 is currently recruiting participants. This phase2 study for borderline resectable pancreatic ductal adenocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Roswell Park Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06821997 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06821997 was last updated Apr 1, 2026 (April 1, 2026). HelloStudys verifies this status automatically.